Cargando…
Neuropilin-1 as a new potential SARS-CoV-2 infection mediator implicated in the neurologic features and central nervous system involvement of COVID-19
Infection by the severe acute respiratory syndrome (SARS) coronavirus-2 (SARS-CoV-2) is the cause of the new viral infectious disease (coronavirus disease 2019; COVID-19). Emerging evidence indicates that COVID-19 may be associated with a wide spectrum of neurological symptoms and complications with...
Autores principales: | Davies, Julie, Randeva, Harpal S., Chatha, Kamaljit, Hall, Marcia, Spandidos, Demetrios A., Karteris, Emmanouil, Kyrou, Ioannis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7533503/ https://www.ncbi.nlm.nih.gov/pubmed/33000221 http://dx.doi.org/10.3892/mmr.2020.11510 |
Ejemplares similares
-
Co-expression of peripheral olfactory receptors with SARS-CoV-2 infection mediators: Potential implications beyond loss of smell as a COVID-19 symptom
por: Kerslake, Rachel, et al.
Publicado: (2020) -
Not only ACE2—the quest for additional host cell mediators of SARS-CoV-2 infection: Neuropilin-1 (NRP1) as a novel SARS-CoV-2 host cell entry mediator implicated in COVID-19
por: Kyrou, Ioannis, et al.
Publicado: (2021) -
Pan-cancer analysis of transmembrane protease serine 2 and cathepsin L that mediate cellular SARS-CoV-2 infection leading to COVID-19
por: Katopodis, Periklis, et al.
Publicado: (2020) -
COVID-19 and SARS-CoV-2 host cell entry mediators: Expression profiling of TMRSS4 in health and disease
por: Katopodis, Periklis, et al.
Publicado: (2021) -
Polycystic ovary syndrome (PCOS) and COVID-19: an overlooked female patient population at potentially higher risk during the COVID-19 pandemic
por: Kyrou, Ioannis, et al.
Publicado: (2020)